Overview

Marjorie Havrenne is an associate in the Corporate and M&A practice of Tauil & Chequer Advogados in the São Paulo office. Her main area of expertise is Shareholders’ Relations and Corporate Governance, focusing on publicly-held companies and the preparation and disclosure of their periodic and occasional information.

Spoken Languages

  • Portuguese
  • English
  • Spanish
  • French

Experience

  • Advisor to Ecorodovias Infraestrutura e Logística S.A. in its Annual and Extraordinary Shareholders' Meeting (organization, drafting of all related documents, personal attendance) / Review of its Informe CBGC (Corporate Governance Form requested by Brazilian regulation) / Assistance on daily corporate matters;
  • Advisor to Braskem S.A. in its Annual and Extraordinary Shareholders' Meeting (organization, drafting of all related documents, personal attendance) / Drafting and Review of its Reference Form / Drafting and review of its Informe CBGC / Assistance on daily corporate matters;
  • Advisor to CCR S.A. in its Annual and Extraordinary Shareholders' Meeting / Drafting and Review of its Reference Form / Review of its Informe CBGC / Assistance on daily corporate matters;
  • Project Manager at Kellogg School of Business (Northwestern University – IL/US), responsible for the Evening & Weekend and Executive MBA cohorts / Design of courses / Research / Complex Data Analysis;
  • In-House Counsel of Brasil Pharma S.A. with regards to its private debt issuance in the approximate amount of R$15M;
  • In-House Counsel of Brasil Pharma S.A. with regards to its capital increase in the approximate amount of R$400M;
  • In-House Counsel of Brasil Pharma S.A. with regards to its public debt issuance (ICVM 400) in the approximate amount of R$288M;
  • In-House Counsel of Brasil Pharma S.A. with regards to its Follow-On that raised the approximate amount of R$553M;
  • In-House Counsel of Brasil Pharma S.A. with regards to its debt issuance (ICVM 476) in the approximate amount of R$250M;
  • In-House Counsel of Brasil Pharma S.A. with regards to the acquisition of the corporate control of Sant’Ana S.A. Drogaria Farmácias for the approximate amount of R$497M;
  • In-House Counsel of Brasil Pharma S.A. with regards to the acquisition of the corporate control of Grupo Farmacêutico Big Benn for the approximate amount of R$454M;
  • In-House Counsel of Brasil Pharma S.A. with regards to the acquisition of the corporate control of Beauty’in Comércio de Bebidas e Cosméticos Ltda. for the approximate amount of R$31M;
  • In-House Counsel of Brasil Pharma S.A. with regards to the acquisition of Farmácia Morimoto Ltda. (“Estrela Galdino”) for the approximate amount of de R$14M;
  • In-House Counsel of Brasil Pharma S.A. with regards to its IPO that raised the approximate amount of R$414M;
  • Advisor to the underwriters in the IPO of OSX Brasil S.A., that raised the approximate amount of R$2.4B;
  • Advisor to the underwriters in the IPO of Banco Santander Brasil S.A., that raised the approximate amount of R$14B;
  • Advisor to the company in the IPO of Fleury S.A., that raised the approximate amount of R$414M;
  • Advisor to the underwriters in the IPO of OGX Petróleo e Gás Participações S.A., that raised the approximate amount of R$6.7B;
  • Advisor to the company in the IPO of Agrenco Netherlands N.V., that raised the approximate amount of R$666M;
  • Advisor to the company in the IPO of TPI – Triunfo Participações e Investimentos S.A., that raised the approximate amount of R$513M;
  • Advisor to one of the biggest power generation companies in its bidding processes throughout the year of 2007;
  • Advisor to several wind power generation companies in their project finance transactions throughout the year of 2007;

Education

FIA-USP

Insper, Mergers and Acquisitions

Universidade Presbiteriana Mackenzie, Bachelor of Law (JD equivalent)

Admissions

Bar

  • Brazil